dc.contributor.author | Hagen, Knut | |
dc.contributor.author | Hopstock, Laila Arnesdatter | |
dc.contributor.author | Eggen, Anne Elise | |
dc.contributor.author | Mathiesen, Ellisiv B. | |
dc.contributor.author | Nilsen, Kristian Bernhard | |
dc.date.accessioned | 2019-06-07T07:01:59Z | |
dc.date.available | 2019-06-07T07:01:59Z | |
dc.date.issued | 2019-03-12 | |
dc.description.abstract | <p><i>Background - </i>The relationship between high sensitivity C-reactive protein and migraine is unclear. The aim of this cross-sectional population-based study was to investigate the association between high sensitivity C-reactive protein and types of headache, and to evaluate the impact of insomnia on this association.
<p><i>Methods - </i>A total of 20,486 (63%) out of 32,591 invited, aged ≥40 years or older, participated in the seventh wave of the Tromsø study conducted in 2015–2016 and had valid information on headache, insomnia and high sensitivity C-reactive protein. The influence of insomnia on the association between questionnaire-based diagnoses of headache and elevated high sensitivity C-reactive protein defined as >3.0 mg/L was assessed using multiple logistic regression, estimating prevalence odds ratio with 95% confidence intervals.
<p><i>Results - </i>A total of 6290 participants (30.7%) suffered from headache during the last year. Among these, 1736 (8.5%) fulfilled the criteria of migraine, 991 (4.8%) had migraine with aura, 746 (3.6%) migraine without aura (3.8%), and 4554 (22.2%) had non-migrainous headache. In the final multi-adjusted analysis, elevated high sensitivity C-reactive protein was associated with headache (odds ratio 1.10, 95% confidence interval 1.01–1.20), migraine (odds ratio 1.17, 95% confidence interval 1.01–1.35), and migraine with aura (odds ratio 1.23, 95% confidence interval 1.01–1.53). No association was found between elevated high sensitivity C-reactive protein and migraine without aura or non-migrainous headache. The association between high sensitivity C-reactive protein and migraine was strongly dependent on insomnia status. Among individuals with insomnia, elevated high sensitivity C-reactive protein was associated with migraine (odds ratio 1.49, 95% confidence interval 1.02–2.17), and migraine with aura (odds ratio 1.59, 95% confidence interval 1.03–2.45), whereas no such relationship was found among those without insomnia.
<p><i>Conclusions - </i>In this cross-sectional study, participants with migraine, in particular migraine with aura, were more likely to have elevated high sensitivity C-reactive protein, evident only among those with insomnia. | en_US |
dc.description | Source at <a href=https://doi.org/10.1177%2F0333102418825370>https://doi.org/10.1177%2F0333102418825370</a>. | en_US |
dc.identifier.citation | Hagen, K., Hopstock, L.A., Eggen, A.E., Mathiesen, E.B. & Nilsen, K.B. (2019). Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016. <i>Cephalalgia</i>. https://doi.org/10.1177%2F0333102418825370 | en_US |
dc.identifier.cristinID | FRIDAID 1685770 | |
dc.identifier.doi | 10.1177/0333102418825370 | |
dc.identifier.issn | 0333-1024 | |
dc.identifier.issn | 1468-2982 | |
dc.identifier.uri | https://hdl.handle.net/10037/15477 | |
dc.language.iso | eng | en_US |
dc.publisher | Sage | en_US |
dc.relation.journal | Cephalalgia | |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803 | en_US |
dc.subject | Population-based | en_US |
dc.subject | Cross-sectional | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | DSM-V | en_US |
dc.subject | Headache | en_US |
dc.title | Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016. | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |